Forward Citations = 0

Loading Chart...

12 inventors (with patents filed for the assignee):

Xiaohu Fan (2 out of 10 patents)

Qiuchuan Zhuang (2 out of 2 patents)

Jianbing Zhang (1 out of 3 patents)

4. Fang Liang Zhang (1 out of 13 patents)

5. Shu Wu (1 out of 15 patents)

6. Zhe Zhou (1 out of 3 patents)

7. Xu Fang (1 out of 2 patents)

8. Youguo Peng (1 out of 1 patent)

9. Yue Han (1 out of 2 patents)

10. Manman Lu (1 out of 1 patent)

11. Jie Mao (1 out of 2 patents)

12. Ruixue Wang (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12766192 - ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND METHODS OF USE THEREOF (2026-10-20),

2. 12703759 - CD19 BINDING MOLECULES AND USES THEREOF (2026-08-11),

3. 10407508 - Compositions and methods for increasing protein half-life in a serum (2019-09-10),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#135 in Nanjing

#8,360 in China

Nanjing, China

Nanjing Legend Biotech., Ltd.

Forward Citations = 0

12 inventors:

Xiaohu Fan (2 out of 10 patents)

Qiuchuan Zhuang (2 out of 2 patents)

Jianbing Zhang (1 out of 3 patents)

4. Fang Liang Zhang (1 out of 13 patents)

5. Shu Wu (1 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanjing Legend Biotech., Ltd.. Retrieved from https://idiyas.com/company/nanjing-legend-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]